Table 2.
MNA group | 11q-del group |
Amplification of MYCN | No amplification of MYCN* |
No 11q deletion* | 11q deletion |
Few segmental aberrations (median, 4) | Many segmental aberrations (median, 12) |
Chromosomal breaks on few other chromosomes in addition to chromosome 2 (location of MYCN) | Chromosomal breaks on several chromosomes in addition to chromosome 11 |
Break distribution ”more focused” | Break distribution ”more shotgun-like” |
1p deletion region more proximal on 1p (consensus in 17–32 Mb) | 1p deletion region more distal on 1p (consensus in 0–10.4 Mb) |
Poor prognosis; 8-year survival ∼35% | Poor prognosis; 8-year survival ∼35% |
Median age at diagnosis 21 months | Median age at diagnosis 42 months |
Median survival from diagnosis 16 months | Median survival from diagnosis 40 months |
Significantly higher H2AFX expression† | Significantly lower H2AFX expression† |
Only rare cases of both MNA and 11q-deletion in the same tumor.
In NB primary tumors and cell lines.